Prothena Corporation plc(PRTA)Earnings, Financials & Key Ratios

Key Thesis Takeaways

• Prothena’s financial profile is defined by extreme revenue volatility, as evidenced by a 92.84% year-over-year decline in specific periods, driven by a reliance on non-recurring milestone payments rather than sustainable commercial operations.
• While the company maintains a current ratio of 10.43, the steady erosion of cash reserves from $618.8 million in 2023Q4 to $329.5 million in 2026Q1 highlights the significant capital intensity required to fund its late-stage pipeline.
• Investors should remain cautious, as the occasional profitability, such as the $32.7 million net income in 2026Q1, appears to be an accounting anomaly that fails to mask the persistent structural challenges of its R&D-heavy business model.